Parkinson's Disease Drug Market Report

Global and Region Parkinson's Disease Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：153
  • REPORT CODE：GMM911989
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Parkinson's Disease Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Parkinson's Disease Drugmarket, defines the market attractiveness level of Parkinson's Disease Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Parkinson's Disease Drug industry, describes the types of Parkinson's Disease Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Parkinson's Disease Drug market and the development prospects and opportunities of Parkinson's Disease Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Parkinson's Disease Drug market in Chapter 13.

    By Player:

    • Endo Pharmaceuticals

    • Desitin Arzneimittel

    • Valeant

    • Merck

    • GSK

    • Abbvie

    • Stada Arzneimittel

    • Apokyn

    • Orion

    • Boehringer Ingelheim

    • Akorn

    • Astellas Pharma

    • Teva Pharmaceutical

    • US WorldMeds

    • Kyowa Hakko Kirin Pharma

    • Novartis

    • Astellas Pharma Pharmaceuticals

    By Type:

    • Sinemet-CR

    • Trastal

    • Madopar

    • COMT Inhibitor

    • Others

    By End-User:

    • Under 40 Years Old

    • 40-65 Years Old

    • Above 65 Years Old

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Parkinson's Disease Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Parkinson's Disease Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Parkinson's Disease Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Parkinson's Disease Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Parkinson's Disease Drug Market Analysis and Outlook to 2022

    • 7.1 Global Parkinson's Disease Drug Consumption (2017-2022)

    • 7.2 United States Parkinson's Disease Drug Consumption (2017-2022)

    • 7.3 Europe Parkinson's Disease Drug Consumption (2017-2022)

    • 7.4 China Parkinson's Disease Drug Consumption (2017-2022)

    • 7.5 Japan Parkinson's Disease Drug Consumption (2017-2022)

    • 7.6 India Parkinson's Disease Drug Consumption (2017-2022)

    • 7.7 South Korea Parkinson's Disease Drug Consumption (2017-2022)

    8 Region and Country-wise Parkinson's Disease Drug Market Analysis and Outlook to 2028

    • 8.1 Global Parkinson's Disease Drug Consumption Forecast (2022-2028)

    • 8.2 United States Parkinson's Disease Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Parkinson's Disease Drug Consumption Forecast (2022-2028)

    • 8.4 China Parkinson's Disease Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Parkinson's Disease Drug Consumption Forecast (2022-2028)

    • 8.6 India Parkinson's Disease Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Parkinson's Disease Drug Consumption Forecast (2022-2028)

    9 Global Parkinson's Disease Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Parkinson's Disease Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Sinemet-CR Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Trastal Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Madopar Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global COMT Inhibitor Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Parkinson's Disease Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Under 40 Years Old Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global 40-65 Years Old Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Above 65 Years Old Consumption and Growth Rate (2017-2022)

    10 Global Parkinson's Disease Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Parkinson's Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Sinemet-CR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Trastal Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Madopar Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global COMT Inhibitor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Parkinson's Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Under 40 Years Old Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global 40-65 Years Old Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)

    11 Global Parkinson's Disease Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Parkinson's Disease Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Parkinson's Disease Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Parkinson's Disease Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Parkinson's Disease Drug Market Competitive Analysis

    • 14.1 Endo Pharmaceuticals

      • 14.1.1 Endo Pharmaceuticals Company Details

      • 14.1.2 Endo Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Endo Pharmaceuticals Parkinson's Disease Drug Product and Service

    • 14.2 Desitin Arzneimittel

      • 14.2.1 Desitin Arzneimittel Company Details

      • 14.2.2 Desitin Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Desitin Arzneimittel Parkinson's Disease Drug Product and Service

    • 14.3 Valeant

      • 14.3.1 Valeant Company Details

      • 14.3.2 Valeant Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Valeant Parkinson's Disease Drug Product and Service

    • 14.4 Merck

      • 14.4.1 Merck Company Details

      • 14.4.2 Merck Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck Parkinson's Disease Drug Product and Service

    • 14.5 GSK

      • 14.5.1 GSK Company Details

      • 14.5.2 GSK Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GSK Parkinson's Disease Drug Product and Service

    • 14.6 Abbvie

      • 14.6.1 Abbvie Company Details

      • 14.6.2 Abbvie Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Abbvie Parkinson's Disease Drug Product and Service

    • 14.7 Stada Arzneimittel

      • 14.7.1 Stada Arzneimittel Company Details

      • 14.7.2 Stada Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Stada Arzneimittel Parkinson's Disease Drug Product and Service

    • 14.8 Apokyn

      • 14.8.1 Apokyn Company Details

      • 14.8.2 Apokyn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Apokyn Parkinson's Disease Drug Product and Service

    • 14.9 Orion

      • 14.9.1 Orion Company Details

      • 14.9.2 Orion Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Orion Parkinson's Disease Drug Product and Service

    • 14.10 Boehringer Ingelheim

      • 14.10.1 Boehringer Ingelheim Company Details

      • 14.10.2 Boehringer Ingelheim Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Boehringer Ingelheim Parkinson's Disease Drug Product and Service

    • 14.11 Akorn

      • 14.11.1 Akorn Company Details

      • 14.11.2 Akorn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Akorn Parkinson's Disease Drug Product and Service

    • 14.12 Astellas Pharma

      • 14.12.1 Astellas Pharma Company Details

      • 14.12.2 Astellas Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Astellas Pharma Parkinson's Disease Drug Product and Service

    • 14.13 Teva Pharmaceutical

      • 14.13.1 Teva Pharmaceutical Company Details

      • 14.13.2 Teva Pharmaceutical Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Teva Pharmaceutical Parkinson's Disease Drug Product and Service

    • 14.14 US WorldMeds

      • 14.14.1 US WorldMeds Company Details

      • 14.14.2 US WorldMeds Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 US WorldMeds Parkinson's Disease Drug Product and Service

    • 14.15 Kyowa Hakko Kirin Pharma

      • 14.15.1 Kyowa Hakko Kirin Pharma Company Details

      • 14.15.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product and Service

    • 14.16 Novartis

      • 14.16.1 Novartis Company Details

      • 14.16.2 Novartis Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Novartis Parkinson's Disease Drug Product and Service

    • 14.17 Astellas Pharma Pharmaceuticals

      • 14.17.1 Astellas Pharma Pharmaceuticals Company Details

      • 14.17.2 Astellas Pharma Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Astellas Pharma Pharmaceuticals Parkinson's Disease Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Parkinson's Disease Drug

    • Figure Parkinson's Disease Drug Picture

    • Table Global Parkinson's Disease Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Parkinson's Disease Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Parkinson's Disease Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Parkinson's Disease Drug Consumption by Country (2017-2022)

    • Figure United States Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure China Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure India Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sinemet-CR Consumption and Growth Rate (2017-2022)

    • Figure Global Trastal Consumption and Growth Rate (2017-2022)

    • Figure Global Madopar Consumption and Growth Rate (2017-2022)

    • Figure Global COMT Inhibitor Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Under 40 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global 40-65 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global Above 65 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global Sinemet-CR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Trastal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Madopar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global COMT Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Under 40 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 40-65 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Parkinson's Disease Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Parkinson's Disease Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Endo Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Endo Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo Pharmaceuticals Parkinson's Disease Drug Product and Service

    • Table Desitin Arzneimittel (Foundation Year, Company Profile and etc.)

    • Table Desitin Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Desitin Arzneimittel Parkinson's Disease Drug Product and Service

    • Table Valeant (Foundation Year, Company Profile and etc.)

    • Table Valeant Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Parkinson's Disease Drug Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Parkinson's Disease Drug Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Parkinson's Disease Drug Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Parkinson's Disease Drug Product and Service

    • Table Stada Arzneimittel (Foundation Year, Company Profile and etc.)

    • Table Stada Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stada Arzneimittel Parkinson's Disease Drug Product and Service

    • Table Apokyn (Foundation Year, Company Profile and etc.)

    • Table Apokyn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apokyn Parkinson's Disease Drug Product and Service

    • Table Orion (Foundation Year, Company Profile and etc.)

    • Table Orion Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orion Parkinson's Disease Drug Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Parkinson's Disease Drug Product and Service

    • Table Akorn (Foundation Year, Company Profile and etc.)

    • Table Akorn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akorn Parkinson's Disease Drug Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Parkinson's Disease Drug Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Parkinson's Disease Drug Product and Service

    • Table US WorldMeds (Foundation Year, Company Profile and etc.)

    • Table US WorldMeds Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table US WorldMeds Parkinson's Disease Drug Product and Service

    • Table Kyowa Hakko Kirin Pharma (Foundation Year, Company Profile and etc.)

    • Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Parkinson's Disease Drug Product and Service

    • Table Astellas Pharma Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Pharmaceuticals Parkinson's Disease Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US